# Top 50 Disease Information Websites (Recommended Ranking) …
Page Info
Writer Joshuaa
Hit 379 Hits
Date 26-01-25 17:03
Content
# Top 50 Disease Information Websites (Recommended Ranking)
# 질병 정보 사이트 추천 순위 TOP 50
Below is a **recommended ranking (not a traffic ranking)** of the best disease/health information websites, prioritized by:
**Trustworthiness (government / university hospitals / evidence-based)** + **Practical usefulness (symptoms, diagnosis, treatment, prevention, “when to seek help”)** + **Accessibility (free, searchable, readable).**
---
## 🇬🇧 English (Primary) — Top 50 Disease Information Websites
**Legend**
* **[Gov/Public]** government or public health authority
* **[Hospital/University]** major hospital / academic health system
* **[Clinical Manual]** medical manuals (consumer/professional style)
* **[Evidence/DB]** research evidence or databases
* **[Rare/Genetics]** rare disease / genetics focus
* **[Foundation/NGO]** disease-focused nonprofit
* **[Media (Caution)]** easy to read but requires cross-checking
---
### 1–10: Global “first-stop” sources (very safe starting points)
1. **WHO – Fact Sheets / Health Topics** [Gov/Public] — global-standard disease summaries, prevention, risk factors
2. **MedlinePlus (NIH/NLM)** [Gov/Public] — patient-friendly, extremely broad coverage with reliable references
3. **CDC (Centers for Disease Control and Prevention)** [Gov/Public] — best for infectious diseases, outbreaks, prevention, public guidance
4. **NHS (UK) Health A to Z** [Gov/Public] — excellent “what to do now / when to get help” style guidance
5. **Mayo Clinic – Diseases & Conditions** [Hospital/University] — clear explanations + practical diagnosis/treatment overview
6. **Cleveland Clinic – Health Library** [Hospital/University] — strong on tests, procedures, recovery and everyday care
7. **MSD Manuals / Merck Manual (Consumer)** [Clinical Manual] — structured, comprehensive, medically solid
8. **Johns Hopkins Medicine – Health** [Hospital/University] — strong specialist-level summaries with patient clarity
9. **Mount Sinai – Health Library** [Hospital/University] — balanced coverage: symptoms → tests → treatment → prognosis
10. **Stanford Health Care – Health Library** [Hospital/University] — helpful for understanding treatment pathways & options
---
### 11–14: High-quality public health portals (non-US)
11. **healthdirect Australia** [Gov/Public] — strong symptom guidance and “when to seek urgent care” logic
12. **Better Health Channel (Victoria, AU)** [Gov/Public] — prevention + lifestyle management is excellent
13. **Government of Canada – Health** [Gov/Public] — strong vaccination / infectious + public health resources
14. **Singapore HealthHub** [Gov/Public] — well-structured public guidance for common conditions and prevention
---
### 15–22: Korea (best Korean-language / Korea-specific practical sources)
15. **National Health Information Portal (KDCA)** [Gov/Public – Korea] — Korea’s official disease & health information hub
16. **KDCA Infectious Disease Portal / Guidance** [Gov/Public – Korea] — outbreak, transmission, prevention, reporting style info
17. **Seoul National University Hospital (SNUH) Medical Info** [Hospital/University – Korea] — academically detailed, low commercial bias
18. **Asan Medical Center – Disease Encyclopedia** [Hospital/University – Korea] — patient-friendly, rich volume, easy navigation
19. **National Cancer Information Center (Korea)** [Gov/Public – Korea] — Korea’s standard cancer guidance hub
20. **HIRA (Health Insurance Review & Assessment) – Disease Statistics** [Gov/Public – Korea] — Korea-specific trends by age/season/utilization
21. **NHIS (National Health Insurance) – Health iN** [Gov/Public – Korea] — screenings, chronic management, lifestyle health tools
22. **MFDS Drug Safety / NEDRUG (Korea)** [Gov/Public – Korea] — medication ingredients, dosing, interactions, precautions
---
### 23–30: Japan / France / Spain / EU (excellent local-language references)
23. **e-Health Net (Japan, MHLW)** [Gov/Public – Japan] — lifestyle disease prevention and evidence-based education
24. **Cancer Information Service (Japan, NCCI)** [Gov/Public – Japan] — Japan’s national-level cancer knowledge base
25. **MSD Manuals (Japanese Consumer)** [Clinical Manual] — structured disease explanations in Japanese
26. **ameli.fr (France) – Health A–Z** [Gov/Public – France] — practical patient explanations, healthcare usage guidance
27. **Santé publique France** [Gov/Public – France] — surveillance, public health reports and prevention
28. **Spain Ministry of Health (Ministerio de Sanidad)** [Gov/Public – Spain] — national policy + prevention guidance
29. **PAHO/WHO (Pan American) Fact Sheets** [Gov/Public – Spanish] — strong disease fact sheets for LATAM context
30. **ECDC (European Centre for Disease Prevention and Control)** [Gov/Public – EU] — infectious disease monitoring, risk assessment
---
### 31–35: Rare diseases & genetics (best-in-class references)
31. **Orphanet** [Rare/Genetics] — Europe’s top rare disease hub (definitions, coding, references)
32. **GARD (NIH Rare Diseases)** [Rare/Genetics] — clear explanations for rare conditions
33. **NORD** [Rare/Genetics/Foundation] — patient support + rare disease summaries
34. **OMIM (NCBI/NIH)** [Rare/Genetics/DB] — gold-standard gene–phenotype database
35. **GeneReviews (NCBI Bookshelf)** [Rare/Genetics/DB] — clinical management + genetic counseling style summaries
---
### 36–40: Evidence & research-level verification tools
36. **PubMed** [Evidence/DB] — research papers (best for “what is the evidence?”)
37. **Cochrane Library** [Evidence] — systematic reviews (high-level evidence strength)
38. **NICE Guidance (UK)** [Evidence/Guideline] — clinical recommendations by condition
39. **ClinicalTrials.gov** [Evidence/Trials] — what treatments are being tested right now
40. **FamilyDoctor.org (AAFP)** [Foundation/NGO] — practical “real-life clinic” style patient guidance
---
### 41–47: High-quality disease foundations (deep practical help)
41. **American Cancer Society** [Foundation/NGO] — prevention, screening, treatment side effects support
42. **NCI – Cancer.gov** [Gov/Public – US] — national cancer reference, research-linked explanations
43. **American Heart Association** [Foundation/NGO] — emergency recognition + prevention excellence
44. **American Diabetes Association** [Foundation/NGO] — management of diabetes + complications guidance
45. **National Kidney Foundation** [Foundation/NGO] — CKD stages, diet, dialysis understanding
46. **Alzheimer’s Association** [Foundation/NGO] — dementia caregiving + symptom progression support
47. **Parkinson’s Foundation** [Foundation/NGO] — rehab, medication, daily living strategies
---
### 48–50: Easy-reading media (use with caution, cross-check always)
48. **WebMD** [Media (Caution)] — very readable, but ads + simplification risk
49. **Healthline** [Media (Caution)] — good readability; verify references and dates
50. **Medical News Today** [Media (Caution)] — current topics, but treat as secondary confirmation only
---
## 🇬🇧 English — The safest way to use this Top 50 list (critical workflow)
### A) The “5-step reading order” that prevents misinformation
**Step 1 (Overview)**: WHO / MedlinePlus / CDC / NHS
* Understand: definition, main causes, typical symptoms, prevention logic
**Step 2 (Clinical detail)**: Mayo / Cleveland / MSD Manuals / Hopkins
* Confirm: tests, diagnosis criteria, treatment options, recovery timeline
**Step 3 (Country-specific reality)**
* If you are in Korea: KDCA + major hospital encyclopedias + HIRA + MFDS drug database
* This makes your info match local terminology, guidelines, and real-world care pathways
**Step 4 (Evidence strength)**: Cochrane + NICE
* Confirm whether a treatment is truly effective, and in what patient groups
**Step 5 (Rare / genetic)**: Orphanet + GARD + OMIM + GeneReviews
* Use these when the disease is uncommon, hereditary, or repeatedly “unclear” after normal searching
---
### B) The 7-point credibility checklist (use this on ANY medical page)
1. **Who wrote it?** Government / university hospital / national foundation is best
2. **Last updated date** visible and recent (medicine changes)
3. **References** to studies/guidelines or clear source citations
4. **Balanced tone**: benefits + risks + limitations (not hype)
5. **No product pushing** (supplement/miracle cure selling = high risk)
6. **Red flags** clearly stated (emergency signs)
7. **Language quality** avoids guaranteed promises (“100% cure”, “secret method”, “instant fix”)
---
### C) Symptom searching: how people get misled (and how to avoid it)
A symptom is **not one disease**. One symptom can map to **dozens** of diseases.
Use this pattern:
* **Symptom → Red Flags → Tests → Differential diagnosis → Treatment & timeline**
Examples of Red Flags:
* sudden severe pain, weakness/paralysis, confusion, breathing difficulty
* chest pain with sweating/nausea
* blood in urine/stool, fainting, high fever with stiff neck
This method prevents “panic searching” and reduces wrong conclusions.
---
### D) Media sites (48–50): safe usage rules
Use WebMD/Healthline/MNT only for:
* quick understanding of basic terms
* “what questions should I ask a doctor?”
Then verify with:
* government/hospital sites
* evidence sources like Cochrane/NICE
Especially for supplements, alternative therapies, or “new miracle treatments.”
---
## 🇰🇷 한국어 — 같은 내용 요약 (영어가 우선이므로 간결 버전)
위 50개는 **방문자 순위가 아니라 “추천 신뢰도 순위”**입니다.
가장 안전한 사용법은 **1~4위로 큰 틀 → 5~10위로 검사·치료 디테일 → 한국이면 15~22위로 국내 기준/약 정보 → 37~39위로 근거 확인 → 31~35위로 희귀·유전 정리** 순서입니다.
미디어형(WebMD/Healthline/MNT)은 **읽기 쉬운 대신 최종 판단은 공공·대학병원으로 교차검증**해야 안전합니다.
---
## 🇯🇵 日本語 — 要点まとめ
最初は **WHO / MedlinePlus / CDC / NHS** で全体像、次に **大病院系**（Mayo / Cleveland / MSD）で検査と治療を確認。根拠は **Cochrane / NICE**、希少疾患は **Orphanet / GARD / OMIM / GeneReviews**。メディア系は必ず二重チェック。
---
## 🇪🇸 Español — Resumen práctico
Empieza con **WHO/MedlinePlus/CDC/NHS**, confirma con **Mayo/Cleveland/MSD**, evidencia con **Cochrane/NICE**, ensayos con **ClinicalTrials.gov**, raras con **Orphanet/GARD/OMIM/GeneReviews**. Sitios de medios: lectura rápida + verificación obligatoria.
---
## 🇫🇷 Français — Résumé d’usage
Base fiable: **OMS/WHO, MedlinePlus, CDC, NHS**. Approfondir: **Mayo, Cleveland, MSD**. Preuves: **Cochrane, NICE**. Essais: **ClinicalTrials.gov**. Rares: **Orphanet, GARD, OMIM, GeneReviews**. Sites médias: toujours vérifier via sources institutionnelles.
---
### Quick reference (official home pages)
```text
WHO: https://www.who.int/
MedlinePlus: https://medlineplus.gov/
CDC: https://www.cdc.gov/
NHS: https://www.nhs.uk/
Mayo Clinic: https://www.mayoclinic.org/
Cleveland Clinic: https://my.clevelandclinic.org/
MSD Manuals: https://www.msdmanuals.com/
KDCA (Korea): https://health.kdca.go.kr/
HIRA (Korea): https://www.hira.or.kr/
Orphanet: https://www.orpha.net/
PubMed: https://pubmed.ncbi.nlm.nih.gov/
Cochrane: https://www.cochranelibrary.com/
NICE: https://www.nice.org.uk/
ClinicalTrials.gov: https://clinicaltrials.gov/
```
# 질병 정보 사이트 추천 순위 TOP 50
Below is a **recommended ranking (not a traffic ranking)** of the best disease/health information websites, prioritized by:
**Trustworthiness (government / university hospitals / evidence-based)** + **Practical usefulness (symptoms, diagnosis, treatment, prevention, “when to seek help”)** + **Accessibility (free, searchable, readable).**
---
## 🇬🇧 English (Primary) — Top 50 Disease Information Websites
**Legend**
* **[Gov/Public]** government or public health authority
* **[Hospital/University]** major hospital / academic health system
* **[Clinical Manual]** medical manuals (consumer/professional style)
* **[Evidence/DB]** research evidence or databases
* **[Rare/Genetics]** rare disease / genetics focus
* **[Foundation/NGO]** disease-focused nonprofit
* **[Media (Caution)]** easy to read but requires cross-checking
---
### 1–10: Global “first-stop” sources (very safe starting points)
1. **WHO – Fact Sheets / Health Topics** [Gov/Public] — global-standard disease summaries, prevention, risk factors
2. **MedlinePlus (NIH/NLM)** [Gov/Public] — patient-friendly, extremely broad coverage with reliable references
3. **CDC (Centers for Disease Control and Prevention)** [Gov/Public] — best for infectious diseases, outbreaks, prevention, public guidance
4. **NHS (UK) Health A to Z** [Gov/Public] — excellent “what to do now / when to get help” style guidance
5. **Mayo Clinic – Diseases & Conditions** [Hospital/University] — clear explanations + practical diagnosis/treatment overview
6. **Cleveland Clinic – Health Library** [Hospital/University] — strong on tests, procedures, recovery and everyday care
7. **MSD Manuals / Merck Manual (Consumer)** [Clinical Manual] — structured, comprehensive, medically solid
8. **Johns Hopkins Medicine – Health** [Hospital/University] — strong specialist-level summaries with patient clarity
9. **Mount Sinai – Health Library** [Hospital/University] — balanced coverage: symptoms → tests → treatment → prognosis
10. **Stanford Health Care – Health Library** [Hospital/University] — helpful for understanding treatment pathways & options
---
### 11–14: High-quality public health portals (non-US)
11. **healthdirect Australia** [Gov/Public] — strong symptom guidance and “when to seek urgent care” logic
12. **Better Health Channel (Victoria, AU)** [Gov/Public] — prevention + lifestyle management is excellent
13. **Government of Canada – Health** [Gov/Public] — strong vaccination / infectious + public health resources
14. **Singapore HealthHub** [Gov/Public] — well-structured public guidance for common conditions and prevention
---
### 15–22: Korea (best Korean-language / Korea-specific practical sources)
15. **National Health Information Portal (KDCA)** [Gov/Public – Korea] — Korea’s official disease & health information hub
16. **KDCA Infectious Disease Portal / Guidance** [Gov/Public – Korea] — outbreak, transmission, prevention, reporting style info
17. **Seoul National University Hospital (SNUH) Medical Info** [Hospital/University – Korea] — academically detailed, low commercial bias
18. **Asan Medical Center – Disease Encyclopedia** [Hospital/University – Korea] — patient-friendly, rich volume, easy navigation
19. **National Cancer Information Center (Korea)** [Gov/Public – Korea] — Korea’s standard cancer guidance hub
20. **HIRA (Health Insurance Review & Assessment) – Disease Statistics** [Gov/Public – Korea] — Korea-specific trends by age/season/utilization
21. **NHIS (National Health Insurance) – Health iN** [Gov/Public – Korea] — screenings, chronic management, lifestyle health tools
22. **MFDS Drug Safety / NEDRUG (Korea)** [Gov/Public – Korea] — medication ingredients, dosing, interactions, precautions
---
### 23–30: Japan / France / Spain / EU (excellent local-language references)
23. **e-Health Net (Japan, MHLW)** [Gov/Public – Japan] — lifestyle disease prevention and evidence-based education
24. **Cancer Information Service (Japan, NCCI)** [Gov/Public – Japan] — Japan’s national-level cancer knowledge base
25. **MSD Manuals (Japanese Consumer)** [Clinical Manual] — structured disease explanations in Japanese
26. **ameli.fr (France) – Health A–Z** [Gov/Public – France] — practical patient explanations, healthcare usage guidance
27. **Santé publique France** [Gov/Public – France] — surveillance, public health reports and prevention
28. **Spain Ministry of Health (Ministerio de Sanidad)** [Gov/Public – Spain] — national policy + prevention guidance
29. **PAHO/WHO (Pan American) Fact Sheets** [Gov/Public – Spanish] — strong disease fact sheets for LATAM context
30. **ECDC (European Centre for Disease Prevention and Control)** [Gov/Public – EU] — infectious disease monitoring, risk assessment
---
### 31–35: Rare diseases & genetics (best-in-class references)
31. **Orphanet** [Rare/Genetics] — Europe’s top rare disease hub (definitions, coding, references)
32. **GARD (NIH Rare Diseases)** [Rare/Genetics] — clear explanations for rare conditions
33. **NORD** [Rare/Genetics/Foundation] — patient support + rare disease summaries
34. **OMIM (NCBI/NIH)** [Rare/Genetics/DB] — gold-standard gene–phenotype database
35. **GeneReviews (NCBI Bookshelf)** [Rare/Genetics/DB] — clinical management + genetic counseling style summaries
---
### 36–40: Evidence & research-level verification tools
36. **PubMed** [Evidence/DB] — research papers (best for “what is the evidence?”)
37. **Cochrane Library** [Evidence] — systematic reviews (high-level evidence strength)
38. **NICE Guidance (UK)** [Evidence/Guideline] — clinical recommendations by condition
39. **ClinicalTrials.gov** [Evidence/Trials] — what treatments are being tested right now
40. **FamilyDoctor.org (AAFP)** [Foundation/NGO] — practical “real-life clinic” style patient guidance
---
### 41–47: High-quality disease foundations (deep practical help)
41. **American Cancer Society** [Foundation/NGO] — prevention, screening, treatment side effects support
42. **NCI – Cancer.gov** [Gov/Public – US] — national cancer reference, research-linked explanations
43. **American Heart Association** [Foundation/NGO] — emergency recognition + prevention excellence
44. **American Diabetes Association** [Foundation/NGO] — management of diabetes + complications guidance
45. **National Kidney Foundation** [Foundation/NGO] — CKD stages, diet, dialysis understanding
46. **Alzheimer’s Association** [Foundation/NGO] — dementia caregiving + symptom progression support
47. **Parkinson’s Foundation** [Foundation/NGO] — rehab, medication, daily living strategies
---
### 48–50: Easy-reading media (use with caution, cross-check always)
48. **WebMD** [Media (Caution)] — very readable, but ads + simplification risk
49. **Healthline** [Media (Caution)] — good readability; verify references and dates
50. **Medical News Today** [Media (Caution)] — current topics, but treat as secondary confirmation only
---
## 🇬🇧 English — The safest way to use this Top 50 list (critical workflow)
### A) The “5-step reading order” that prevents misinformation
**Step 1 (Overview)**: WHO / MedlinePlus / CDC / NHS
* Understand: definition, main causes, typical symptoms, prevention logic
**Step 2 (Clinical detail)**: Mayo / Cleveland / MSD Manuals / Hopkins
* Confirm: tests, diagnosis criteria, treatment options, recovery timeline
**Step 3 (Country-specific reality)**
* If you are in Korea: KDCA + major hospital encyclopedias + HIRA + MFDS drug database
* This makes your info match local terminology, guidelines, and real-world care pathways
**Step 4 (Evidence strength)**: Cochrane + NICE
* Confirm whether a treatment is truly effective, and in what patient groups
**Step 5 (Rare / genetic)**: Orphanet + GARD + OMIM + GeneReviews
* Use these when the disease is uncommon, hereditary, or repeatedly “unclear” after normal searching
---
### B) The 7-point credibility checklist (use this on ANY medical page)
1. **Who wrote it?** Government / university hospital / national foundation is best
2. **Last updated date** visible and recent (medicine changes)
3. **References** to studies/guidelines or clear source citations
4. **Balanced tone**: benefits + risks + limitations (not hype)
5. **No product pushing** (supplement/miracle cure selling = high risk)
6. **Red flags** clearly stated (emergency signs)
7. **Language quality** avoids guaranteed promises (“100% cure”, “secret method”, “instant fix”)
---
### C) Symptom searching: how people get misled (and how to avoid it)
A symptom is **not one disease**. One symptom can map to **dozens** of diseases.
Use this pattern:
* **Symptom → Red Flags → Tests → Differential diagnosis → Treatment & timeline**
Examples of Red Flags:
* sudden severe pain, weakness/paralysis, confusion, breathing difficulty
* chest pain with sweating/nausea
* blood in urine/stool, fainting, high fever with stiff neck
This method prevents “panic searching” and reduces wrong conclusions.
---
### D) Media sites (48–50): safe usage rules
Use WebMD/Healthline/MNT only for:
* quick understanding of basic terms
* “what questions should I ask a doctor?”
Then verify with:
* government/hospital sites
* evidence sources like Cochrane/NICE
Especially for supplements, alternative therapies, or “new miracle treatments.”
---
## 🇰🇷 한국어 — 같은 내용 요약 (영어가 우선이므로 간결 버전)
위 50개는 **방문자 순위가 아니라 “추천 신뢰도 순위”**입니다.
가장 안전한 사용법은 **1~4위로 큰 틀 → 5~10위로 검사·치료 디테일 → 한국이면 15~22위로 국내 기준/약 정보 → 37~39위로 근거 확인 → 31~35위로 희귀·유전 정리** 순서입니다.
미디어형(WebMD/Healthline/MNT)은 **읽기 쉬운 대신 최종 판단은 공공·대학병원으로 교차검증**해야 안전합니다.
---
## 🇯🇵 日本語 — 要点まとめ
最初は **WHO / MedlinePlus / CDC / NHS** で全体像、次に **大病院系**（Mayo / Cleveland / MSD）で検査と治療を確認。根拠は **Cochrane / NICE**、希少疾患は **Orphanet / GARD / OMIM / GeneReviews**。メディア系は必ず二重チェック。
---
## 🇪🇸 Español — Resumen práctico
Empieza con **WHO/MedlinePlus/CDC/NHS**, confirma con **Mayo/Cleveland/MSD**, evidencia con **Cochrane/NICE**, ensayos con **ClinicalTrials.gov**, raras con **Orphanet/GARD/OMIM/GeneReviews**. Sitios de medios: lectura rápida + verificación obligatoria.
---
## 🇫🇷 Français — Résumé d’usage
Base fiable: **OMS/WHO, MedlinePlus, CDC, NHS**. Approfondir: **Mayo, Cleveland, MSD**. Preuves: **Cochrane, NICE**. Essais: **ClinicalTrials.gov**. Rares: **Orphanet, GARD, OMIM, GeneReviews**. Sites médias: toujours vérifier via sources institutionnelles.
---
### Quick reference (official home pages)
```text
WHO: https://www.who.int/
MedlinePlus: https://medlineplus.gov/
CDC: https://www.cdc.gov/
NHS: https://www.nhs.uk/
Mayo Clinic: https://www.mayoclinic.org/
Cleveland Clinic: https://my.clevelandclinic.org/
MSD Manuals: https://www.msdmanuals.com/
KDCA (Korea): https://health.kdca.go.kr/
HIRA (Korea): https://www.hira.or.kr/
Orphanet: https://www.orpha.net/
PubMed: https://pubmed.ncbi.nlm.nih.gov/
Cochrane: https://www.cochranelibrary.com/
NICE: https://www.nice.org.uk/
ClinicalTrials.gov: https://clinicaltrials.gov/
```